Immunogenicity of a Recombinant Hepatitis B Vaccine in Hemodialysis Patients: A Two-Year Follow-Up

Dino Docci,P.A. Cipolloni,Silvia Mengozzi,Leopoldo Baldrati,Claudio Capponcini,Carlo Feletti

Immunogenicity of a Recombinant Hepatitis B Vaccine in Hemodialysis Patients: A Two-Year Follow-Up

1992

Dino Docci
P.A. Cipolloni
Silvia Mengozzi
Leopoldo Baldrati
Claudio Capponcini
Carlo Feletti

The immunogenicity of a recombinant hepatitis B vaccine was evaluated in 35 hemodialysis patients who received a standard dose (20 μg) of the vaccine at 0,1, 2 and 6 months. After the full vaccination

Keywords:

Hepadnaviridae
Virus
Endocrinology
Immunogenicity
Hepatitis B vaccine
Immunology
Hepatitis B virus
Hemodialysis
Internal medicine
Vaccination
Recombinant virus
Medicine
Humoral immunity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations